Biostax
Winter Park, US · Founded 2023 · Florida corporation
Biotech
Founders & leadership
NG
Noreen GriffinExecutive Officer
AD
Angus DalgleishExecutive Officer
SE
Seth ElliottPresident and Chief Operating Officer
PA
Peter AronstamChief Financial Officer
FS
Fengping ShanChief Science Officer
JF
Joseph FortunakExecutive Officer
CP
Christopher PearceDirector
ET
Edward TeraskiewiczDirector
VB
Vincent ButtaDirector
EY
Eugene YoukilisDirector
NP
Nicholas PlotnikoffNon-Executive Chairman of the Board (non-voting director)
Reported raises · per SEC filings
Form D private placements▶$7.5MofferedJun 2026 · 20 investors · BiotechnologyRule 506(b)
▶$7.5MofferedJun 2026 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noreen GriffinExecutive Officer
- Offering amount
- $7.5M
- Minimum investment
- $10K
- First sale
- Dec 2025
- Incorporated
- Corporation, Florida, 2023
- Federal exemptions
- 06b
▶$5MofferedAug 2022 · BiotechnologyRule 506(b)
▶$5MofferedAug 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Roscoe MooreDirector
- Robert WilsonDirector
- Glen FarmerExecutive Officer
- Clifford SelskyDirector
- Cynthia DouglasExecutive Officer
- Noreen GriffinExecutive Officer
- Kevin PhelpsDirector
- Stephen WilsonExecutive Officer, Director
- Kelly WilsonExecutive Officer
- Offering amount
- $5M
- Minimum investment
- $25K
- Sales commissions
- $500K
- Proceeds to insiders
- $120K
- Placement agents
- JBCG Enterprises, Dealbox
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$400KraisedAug 2022 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cynthia DouglasExecutive Officer
- Stephen WilsonExecutive Officer, Director
- Clifford SelskyDirector
- Roscoe MooreDirector
- Kevin PhelpsDirector
- Robert WilsonDirector
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Jul 2022
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$200KraisedApr 2015 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedApr 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher PearceDirector
- Edward TeraskiewiczDirector
- Noreen GriffinExecutive Officer, Director
- Angus DalgleishExecutive Officer
- Vincent ButtaDirector
- Seth ElliottExecutive Officer
- Eugene YoukilisDirector
- Nicholas PlotnikoffDirector
- Peter AronstamExecutive Officer
- Fengping ShanExecutive Officer
- Joseph FortunakExecutive Officer
- Amount sold
- $200K
- First sale
- Mar 2015
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.